FIELD: chemistry.
SUBSTANCE: invention refers to new compounds of general formula (I) or to its pharmaceutically acceptable salts or to it solvates, where m is equal 0 to 3, X stands for N, Y stands for -SO2-, each R1 independently stands for halogen, C1-C12alkyl, halogen(C1-C12)alkyl, hydroxy(C1-C6)alkyl, R2 stands for aryl or heteroaryl which represents monocyclic radical containing 5 to 12 atoms in a cycle, including one, two or three nitrogen heteroatoms in a cycle optionally substituted with halogen or cyano, each R3 and R4 independently stands for C1-C12alkyl, or R3 and R4 together with carbon atom whereto they are attached, form the cyclic group containing 3-6 atoms in a cycle, and each R5, R6, R7, R8 and R9 stands for hydrogen. Besides, the invention concerns the pharmaceutical composition.
EFFECT: preparation of the new biologically active compounds with antagonistic action to 5-NT6 receptor.
15 cl, 6 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS AND METHODS FOR TREATING COGNITIVE DISORDERS | 2005 |
|
RU2420318C2 |
2,5-SUBSTITUTED TETRAHYDROISOQUINOLINE AND A PHARMACEUTICAL MODULATION COMPOSITION 5-НТ6 | 2004 |
|
RU2327689C2 |
NOVEL COMPOUNDS AND USE THEREOF IN THERAPY | 2004 |
|
RU2412190C2 |
BENZOXAZINE AND QUINOXALINE DERIVATIVES AND USE THEREOF | 2005 |
|
RU2382036C2 |
APOPTOSIS-INDUCING AGENTS | 2018 |
|
RU2782469C2 |
OXAZOLIDINE ANTIBIOTICS | 2008 |
|
RU2470022C2 |
BENZOXAZINONE DERIVATIVES AND BASED ON THEM PHARMACEUTICAL COMPOSITION | 2003 |
|
RU2328490C2 |
PYRAZOLAMINOPIRIMIDINE DERIVATIVES AS LEUCINE-REPEATING KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON DISEASE | 2013 |
|
RU2637948C2 |
ANTIBIOTIC DERIVATIVES OF 2-OXO-OXAZOLIDINE-3, 5-DIYL | 2012 |
|
RU2616609C2 |
METHOD OF RESIDUAL LIPOPROTEINS PRODUCING INHIBITION | 2004 |
|
RU2330682C2 |
Authors
Dates
2009-05-10—Published
2004-11-30—Filed